Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report

BACKGROUND: Programmed cell death 1 (PD-1) and its ligand 1 (PD-L1) inhibitors have quickly become standard of care for patients with advanced non-small cell lung cancer and increasing numbers of other cancer types. In this report, we discuss the clinical history, pathological evaluation, and genomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hong, Ma, Weijie, Yoneda, Ken Y., Moore, Elizabeth H., Zhang, Yanhong, Pu, Lee L. Q., Frampton, Garrett M., Molmen, Michael, Stephens, Philip J., Li, Tianhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331657/
https://www.ncbi.nlm.nih.gov/pubmed/28245875
http://dx.doi.org/10.1186/s13045-017-0433-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331657/
https://www.ncbi.nlm.nih.gov/pubmed/28245875
http://dx.doi.org/10.1186/s13045-017-0433-z

Ejemplares similares